dc.contributor.author |
Williams, Sîan A |
|
dc.contributor.author |
Mackey, Anna |
|
dc.contributor.author |
Sorhage, Alexandra |
|
dc.contributor.author |
Battin, Malcolm |
|
dc.contributor.author |
Wilson, Nichola |
|
dc.contributor.author |
Spittle, Alicia |
|
dc.contributor.author |
Stott, N Susan |
|
dc.coverage.spatial |
Australia |
|
dc.date.accessioned |
2022-06-26T23:30:41Z |
|
dc.date.available |
2022-06-26T23:30:41Z |
|
dc.date.issued |
2021-04 |
|
dc.identifier.citation |
(2021). Journal of Paediatrics and Child Health, 57(4), 541-547. |
|
dc.identifier.issn |
1034-4810 |
|
dc.identifier.uri |
https://hdl.handle.net/2292/60137 |
|
dc.description.abstract |
<h4>Aim</h4>A diagnosis of cerebral palsy (CP) can, and should, be made as early as possible. This work describes current clinical practice around the awareness and use of diagnostic tools for the detection of CP in New Zealand (NZ).<h4>Methods</h4>A purpose-developed survey distributed electronically to NZ clinicians working with young children with or at risk of CP.<h4>Results</h4>A total of 159 clinicians (including paediatricians, physiotherapists and occupational therapists) participated in this cross-sectional study. Ninety-six percent were aware that a diagnosis of CP can be made by 12 months of age, with high levels of awareness of the use of magnetic resonance imaging (94%), Prechtl's qualitative assessment of general movements (GMs) (70%) and Hammersmith Infant Neurological Examination (HINE) (77%). Only 40% were aware of the HINE optimality scoring. Fifty-four clinicians provided a diagnosis of CP as part of their role: 48% never used the GMs or HINE to assess children <1 year, and 57% never used the HINE for children between 1 and 2 years. Clinicians not providing a diagnosis within their professional role (n = 104) also indicated infrequent use of assessment tools with 74% and 54% never using the GM's or HINE (respectively) in their assessment of children at risk of CP. Barriers to use included lack of time and funding, lack of clear pathways and management support.<h4>Conclusion</h4>Despite high awareness, current use of international best practice tools in NZ clinical practice appears low. Multiple barriers are reported to the use of these tools, which need to be addressed to improve the timeliness of diagnosis. |
|
dc.format.medium |
Print-Electronic |
|
dc.language |
eng |
|
dc.publisher |
Wiley |
|
dc.relation.ispartofseries |
Journal of paediatrics and child health |
|
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
|
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
|
dc.subject |
Humans |
|
dc.subject |
Cerebral Palsy |
|
dc.subject |
Neurologic Examination |
|
dc.subject |
Cross-Sectional Studies |
|
dc.subject |
Movement |
|
dc.subject |
Child |
|
dc.subject |
Child, Preschool |
|
dc.subject |
Infant |
|
dc.subject |
New Zealand |
|
dc.subject |
Hammersmith Infant Neurological Examination |
|
dc.subject |
diagnostic tool |
|
dc.subject |
early diagnosis |
|
dc.subject |
general movements assessment |
|
dc.subject |
Neurosciences |
|
dc.subject |
Pediatric |
|
dc.subject |
Clinical Research |
|
dc.subject |
Brain Disorders |
|
dc.subject |
Prevention |
|
dc.subject |
Perinatal Period - Conditions Originating in Perinatal Period |
|
dc.subject |
4.2 Evaluation of markers and technologies |
|
dc.subject |
Science & Technology |
|
dc.subject |
Life Sciences & Biomedicine |
|
dc.subject |
Pediatrics |
|
dc.subject |
FOLLOW-UP |
|
dc.subject |
IMPLEMENTATION |
|
dc.subject |
INTERVENTION |
|
dc.subject |
GUIDELINES |
|
dc.subject |
DIAGNOSIS |
|
dc.subject |
BARRIERS |
|
dc.subject |
CHILDREN |
|
dc.subject |
CARE |
|
dc.subject |
1103 Clinical Sciences |
|
dc.subject |
1114 Paediatrics and Reproductive Medicine |
|
dc.subject |
1117 Public Health and Health Services |
|
dc.title |
Clinical practice of health professionals working in early detection for infants with or at risk of cerebral palsy across New Zealand. |
|
dc.type |
Journal Article |
|
dc.identifier.doi |
10.1111/jpc.15263 |
|
pubs.issue |
4 |
|
pubs.begin-page |
541 |
|
pubs.volume |
57 |
|
dc.date.updated |
2022-05-29T21:23:01Z |
|
dc.rights.holder |
Copyright: The author |
en |
dc.identifier.pmid |
33217101 (pubmed) |
|
pubs.author-url |
https://www.ncbi.nlm.nih.gov/pubmed/33217101 |
|
pubs.end-page |
547 |
|
pubs.publication-status |
Published |
|
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Journal Article |
|
pubs.elements-id |
828581 |
|
pubs.org-id |
Liggins Institute |
|
pubs.org-id |
Medical and Health Sciences |
|
pubs.org-id |
School of Medicine |
|
pubs.org-id |
Paediatrics Child & Youth Hlth |
|
pubs.org-id |
Surgery Department |
|
dc.identifier.eissn |
1440-1754 |
|
pubs.record-created-at-source-date |
2022-05-30 |
|
pubs.online-publication-date |
2020-11-20 |
|